Search
Coins: 3408
Exchanges: 262
Dominance:
BTC 52.7%
XRP 11.9%
ETH 9.17%
cosmecoin ICO logo (small)

Cosmecoin ICO

Ended
Healthcare

iConsult Software Ltd. has developed a reward based ERC20 token called Cosmecoin (COSX), which will run on the Ethereum Blockchain, for use within the Cosmetic and Medical Aesthetic sector. Cosmecoin will be used as a means to connect patients with trusted practitioners, record the process, protect all parties and reward best practice and engagement. The goal for Cosmecoin is to utilise smart contracts to provide an end-to-end platform for the industry, which increases safety, regulation and trust and reduces complaints and possible future litigation.

Gecko Rating
No Ratings Found
Social Stats
Telegram Users
2,832
Twitter Followers
2,455
YouTube Views
374
Youtube Subscribers
2
Ico Ended
Website Whitepaper
Token Details
  • Whitelist
    -
  • Pre Sale
    9 Apr 2018 - 9 May 2018 (0.0111 USD = 1.0 cosx)
  • Public Sale
    10 May 2018 - 10 Nov 2018 (0.037 USD = 1.0 cosx)
  • Ticker
    cosx
  • Platform
    Ethereum
  • Country
    United Kingdom
  • Accepting
    ETH, BTC, LTC, USD, GBP, EUR
  • Restrictions
    • Italy (Total Restriction)
    • France (Total Restriction)
    • Germany (Total Restriction)
    • Spain (Total Restriction)
    • Japan (Total Restriction)
    • South Korea (Total Restriction)
    • South Africa (Total Restriction)
    • Canada (Total Restriction)
    • China (Total Restriction)
    • United States (Total Restriction)
  • Total Raised
    -
  • Soft Cap
    2,000,000 GBP
  • Hard Cap
    5,000,000 GBP
  • Total Tokens
    -
  • Available For Sale
    -
  • Bounty
    -
  • KYC Required
    true
Team
Team Members
Richard Crawford Small profile picture
Richard Crawford Small
Founder and CEO
Rob Westmacott profile picture
Rob Westmacott
Non Exec Director & Technology Advisor
Chris Barber profile picture
Chris Barber
Chief Tech Officer
Russell Turner profile picture
Russell Turner
Creative Director
Lia Burnell profile picture
Lia Burnell
Community & Marketing Manager
Vladimir Chernyshev profile picture
Vladimir Chernyshev
Sr. Fullstack Developer
Gang Zhu profile picture
Gang Zhu
Blockchain Developer
Pat Maugeri profile picture
Pat Maugeri
General Manager ClinicOS Aus
Mark Nicholson profile picture
Mark Nicholson
Financial Director
Advisors
Shivam Gupta profile picture
Shivam Gupta
Marketing and PR advisor
Dr Ravi Jain profile picture
Dr Ravi Jain
Medical Advisor
Sarah Louise Woodman profile picture
Sarah Louise Woodman
Communications Advisor
Julian Macedo profile picture
Julian Macedo
Commercial Advisor
Charles Weatherstone profile picture
Charles Weatherstone
Industry Advisor
Greg Bran, M.D. PhD profile picture
Greg Bran, M.D. PhD
Medical Advisor
Nikki Zanna profile picture
Nikki Zanna
iConsult Expert User
Rick O'Neill profile picture
Rick O'Neill
Digital Marketing Advisor
Peter Glock profile picture
Peter Glock
Security and Data Protection Advisor
ICOs You May Also Like
MCV-CAP
MCV is combining traditional banking functionalities with blockchain technology
Intrachain
The World's First Process Mining Software with Integrated Blockchain
Minion Coin
The Minion System builds mini-games to extract behavioral pattern data from economics and market research
Cultural Places
Cultural Places is the new social network for the cultural world. Revolutionizing access to cultural content, location based information, cultural ticketing & crowdfunding via blockchain with our own crypto currency – the Cultural Coin.
Verifer
SHIPNEXT is an international Online Shipping Marketplace for dry-bulk and wet bulk, general and oversized cargo, steels and containers.
Foneex
FIRST EVER COMMODITY CRYPTO EXCHANGE Using Blockchain Technology to Eliminate Transaction Fees, Decentralize Account Balances and Creating the World's Most Advanced Commission Free Future Exchange
Airgead Coin
"Airgead Coin is allowing investors the ability to create a worldwide, debt-free currency backed entirely by physical Precious Metals. "
First Investment Token
FITX is the stock and cryptocurrency markets coupling.